If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 66   2005   NUMBER 1

Brainstorms

5 Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder? Stephen M. Stahl
[PDF]

Original Articles

7 Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity. Molly M. Shores, Victoria M. Moceri, Kevin L. Sloan, Alvin M. Matsumoto, and Daniel R. Kivlahan
[Abstract] [PDF]

15 The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation. Jose de Leon, Margaret T. Susce, Run-Mei Pan, Maureen Fairchild, Walter H. Koch, and Peter J. Wedlund
[Abstract] [PDF]

28 Sertraline Treatment of Pathological Gambling: A Pilot Study. Jerónimo Saiz-Ruiz, Carlos Blanco, Angela Ibáñez, Xavier Masramon, Margarita M. Gómez, María Madrigal, and Teresa Díez
[Abstract] [PDF]

34 Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder. David V. Sheehan, Daniel B. Burnham, Malini K. Iyengar, and Philip Perera, for the Paxil CR Panic Disorder Study Group
[Abstract] [PDF]

41 Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction. Charles L. Raison, Andrey S. Borisov, Sherry D. Broadwell, Lucile Capuron, Bobbi J. Woolwine, Ira M. Jacobson, Charles B. Nemeroff, and Andrew H. Miller
[Abstract] [PDF]

49 The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients. Kathryn M. Connor, Victoria M. Payne, Kishore M. Gadde, Wei Zhang, and Jonathan R. T. Davidson
[Abstract] [PDF]

52 Assessing the Utility of Atypical Antipsychotic Medication in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders. Karen J. Shedlack, John Hennen, Christine Magee, and Daniel M. Cheron
[Abstract] [PDF]

63 A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine: Efficacy and Safety. A. Elif Anil Yagcioglu, Berna B. Kivircik Akdede, Tolga I. Turgut, Mevhibe Tümüklü, M. Kâzim Yazici, Köksal Alptekin, Aygün Ertugrul, Karu Jayathilake, Ahmet Gögüs, Zeliha Tunca, and Herbert Y. Meltzer
[Abstract] [PDF]

73 Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study. Ann M. Bogan, Lorrin M. Koran, Helen W. Chuong, Tanya Vapnik, and Alexander Bystritsky
[Abstract] [PDF]

80 Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine. Deanna L. Kelly and Robert R. Conley
[Abstract] [PDF]

85 A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness. Maurizio Fava, Michael E. Thase, and Charles DeBattista
[Abstract] [PDF]

94 Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety Disorder: A Double-Blind, Prospective Comparison Between Paroxetine and Sertraline. Susan G. Ball, Angela Kuhn, Delynda Wall, Anantha Shekhar, and Andrew W. Goddard
[Abstract] [PDF]

100 Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine. Mikael Landén, Per Högberg, and Michael E. Thase
[Abstract] [PDF]

107 Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders. Joseph Bergman, Tzvi Dwolatzky, Izidor Brettholz, and Vladimir Lerner
[Abstract] [PDF]

111 A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder. Charles L. Bowden, Heinz Grunze, Jamie Mullen, Martin Brecher, Björn Paulsson, Martin Jones, Mårten Vågerö, and K. Svensson
[Abstract] [PDF]

Academic Highlights

122 Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia. [CME]
[PDF]

Letters To the Editor

134 Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome." Jambur Ananth
[PDF]

134 Interactions of Cyclobenzaprineand Tricyclic Antidepressants. Nicholas Z. Rosenlicht and Kristin P. Riley-Lazo
[PDF]

135 Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients. S. Tziporah Cohen, Daphne Rulf, and Ronald Pies
[PDF]

136 Problems in Assessing Musical Hallucinations. Robert J. Teunisse · Reply by Haggai Hermesh, Ruth Gross-Isseroff, Shai Konas, Roni Shiloh, Abraham Weizman, Sofi Marom, and Reuven Dar
[PDF]

137 Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics. James L. Karagianis and Eduardo Dunayevich · Reply by Natalie Alméras, Jean-Pierre Després, Julie Villeneuve, Marie-France Demers, and Roch-Hugo Bouchard
[PDF]

138 Corrections. Toki S, Morinobu S, Yoshino A, and Yamawaki S. A Case of Venous Thromboembolism Probably Associated With Hyperprolactinemia After the Addition of Olanzapine to Typical Antipsychotics (J Clin Psychiatry 2004;65:1576-1577); McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu S-C, Capece JA, Fazzio L, and Hudson JI. Topiramate in the Long-Term Treatment of Binge-Eating Disorder Associated With Obesity (J Clin Psychiatry 2004;65:1463-1469)
[PDF]

Book Reviews 139